PremiumCompany AnnouncementsAvicanna Receives Management Cease Trade Order Amid Audit Delays Avicanna Hosts 5th Symposium on Cannabinoid-Based Medicine Avicanna Faces Financial Statement Filing Delay Amid Auditor Issues PremiumThe FlyAvicanna completes first delivery of topical products to pharmaceutical company Avicanna Inc. Reports Strong Growth in Q3 2024 Avicanna Shows Strong Revenue Growth and Improved Margins PremiumThe FlyAvicanna announces repayment of debentures Avicanna Completes Private Placement Fundraising Avicanna Secures US Patent for Pain-Relief Topical Technology